Delivery Order SPE2DX22D0029-SPE2D825F37DB
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, with an ultimate completion date of August 12, 2025. This firm fixed-price delivery order, valued at $3,634.86, represents a non-set-aside, competitively awarded contract issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vehicle through December 2026. AmerisourceBergen, a...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 21, 2025, represents a firm fixed-price contract valued at $3,705.16 for pharmaceutical and medical supply distribution. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense-aligned federal agency supporting military and veteran healthcare systems. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected through competitive...
- This delivery order, awarded on July 30, 2025, to AmerisourceBergen Drug Corp represents a $1,414.15 firm fixed price contract for pharmaceutical products and medical supplies. The award was made by the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency supporting military and veteran healthcare systems. The contract, which is not set aside for small businesses or other designated groups, is performed at AmerisourceBergen's corporate office location in...
- This delivery order, awarded July 21, 2025, represents a $4,038.72 firm fixed-price contract issued to AmerisourceBergen Drug Corp by the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, is a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The order is scheduled for ultimate completion on July 22, 2025,...
- This delivery order, awarded on July 28, 2025, to AmerisourceBergen Drug Corp represents a $61,455.73 firm fixed-price contract funded by the Defense Logistics Agency's Medical Supply Chain for pharmaceutical and medical supply delivery. The contract, with an ultimate completion date of July 29, 2025, is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (valued at $999,999,999.00 through December 2026) with DLA Troop Support Medical. The award was made competitively...
- This delivery order, awarded July 28, 2025, represents a $27,577 firm fixed-price contract between the Defense Logistics Agency's Medical Supply Chain and AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract is a child order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support...
- This delivery order, awarded to AmerisourceBergen Drug Corp on July 22, 2025, represents a $190,227.78 firm fixed-price contract with an ultimate completion date of July 23, 2025. The contract is funded by the Defense Logistics Agency's Medical Supply Chain, a defense agency component, with performance to occur at the vendor's corporate office location in Conshohocken, Pennsylvania. As a non-set-aside award, this delivery order was competitively awarded and reflects AmerisourceBergen's ongoing...
- The Defense Logistics Agency Medical Supply Chain awarded a $3,950.10 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The contract was competitively awarded with no set-aside designation and specifies...
- This delivery order, awarded July 30, 2025, represents a $27,876.18 firm fixed-price contract issued by the Defense Logistics Agency's Medical Supply Chain division to AmerisourceBergen Drug Corp for pharmaceutical and medical supply delivery. The contract, which is a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), is scheduled for completion by August 20, 2025. The award was competitively...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $6,257.70 to AmerisourceBergen Drug Corp on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed-price delivery order, issued without set-aside designation, represents a competitive award to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The contract follows a competitive procurement process, consistent with AmerisourceBergen's established...
- SPE2DX22D0029Indefinite Delivery Contract
- SPE2DX22D0029-SPE2D825F37DBDelivery Order
This delivery order, awarded July 26, 2025, to AmerisourceBergen Drug Corp represents a $3,123.51 firm fixed-price purchase through the Defense Logistics Agency's Medical Supply Chain division. The contract, which is not set-aside and was competitively awarded, has an ultimate completion date of July 28, 2025, with performance at the contractor's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a prime vendor under the DLA's Pharmaceutical Prime Vendor Global Program, AmerisourceBergen supplies a comprehensive range of pharmaceutical products and medical devices to support military healthcare systems worldwide. The delivery order represents one of numerous competitively awarded transactions through which the contractor fulfills federal medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. AmerisourceBergen's role as a critical pharmaceutical distributor for federal medical supply chains demonstrates its capacity to meet diverse military healthcare needs through flexible contract vehicles serving multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 7/26/25 |